36 /100
MEDIUM RISK
Score updated Jul 13, 2026

HPAI — Helport AI Limited Dilution Risk Tracker

Track HPAI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HPAI — Get alerts when the score changes →

As of July 13, 2026, Helport AI Limited (HPAI) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Helport AI Limited has a market capitalization of $39.53M, 37.43M shares outstanding, 11 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
65
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.51 approaching $1 threshold
🔔 Track HPAI — Get forecast alerts →

💹 Market Data

Market Cap$39.53M
Shares Outstanding37.43M
Float7.59M
Cash$152.1K
Debt$5.01M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 0.2% shares (2026Q1 vs prior)
11 institutional holders · 215.7K shares
#1 HIGHBRIDGE CAPITAL MANAGEMENT LLC 37.4K shares
#2 JPMORGAN CHASE & CO 37.4K shares
#3 Polar Asset Management Partners Inc. 29.2K shares
+ 8 more holders Sign up free to view →

📉 Short Interest

Short Interest285.5K
Days to Cover2.0
% of Float3.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Jun 30, 2025
xbrl XBRL WARRANT Jun 30, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for HPAI Shareholders

Helport AI Limited (HPAI) has a DilutionScore of 36/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for HPAI shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for HPAI in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for HPAI alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track HPAI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HPAI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for HPAI
📊 HPAI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HPAI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.